Healthcare Value Capital as of June 30, 2016
Portfolio Holdings for Healthcare Value Capital
Healthcare Value Capital holds 18 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Biosante Pharmaceuticals (ANIP) | 26.7 | $22M | 395k | 55.82 | |
| Spdr S&p 500 Etf (SPY) | 19.0 | $16M | 75k | 209.48 | |
| DepoMed | 10.7 | $8.8M | 450k | 19.62 | |
| Pfizer (PFE) | 7.5 | $6.2M | 175k | 35.21 | |
| Quest Diagnostics Incorporated (DGX) | 6.5 | $5.4M | 66k | 81.41 | |
| CryoLife (AORT) | 6.5 | $5.3M | 450k | 11.82 | |
| Albany Molecular Research | 5.7 | $4.7M | 352k | 13.44 | |
| Qlt | 3.9 | $3.2M | 2.3M | 1.42 | |
| Ultra Short Russell 2000 | 3.2 | $2.6M | 75k | 34.84 | |
| AMAG Pharmaceuticals | 3.0 | $2.5M | 105k | 23.92 | |
| Aralez Pharmaceuticals | 2.6 | $2.2M | 650k | 3.31 | |
| Sagent Pharmaceuticals | 1.5 | $1.3M | 85k | 14.97 | |
| Cytokinetics (CYTK) | 1.1 | $949k | 100k | 9.49 | |
| Proshares Tr Ii vix strmfut etf | 1.1 | $916k | 100k | 9.16 | |
| Zogenix | 0.3 | $256k | 32k | 8.04 | |
| Apricus Bioscience | 0.2 | $176k | 440k | 0.40 | |
| Fibrocell Science | 0.2 | $170k | 148k | 1.15 | |
| Sunesis Pharmaceuticals | 0.1 | $83k | 150k | 0.55 |
